ALK-Abelló A/S ALK-Abelló A/S

ALK-Abelló A/S

ALK-B

Rankning i aktier #2350
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Aktiekurs
$37.76
Marknadsvärde
$8.38B
Förändring (1 dag)
-0.08%
Förändring (1 år)
16.71%
Land
DK
Handel ALK-Abelló A/S (ALK-B)

Kategori

Healthcare
Historik för aktiesplit för ALK-Abelló A/S (ALK-B)
Aktien ALK-Abelló A/S (symbol: ALK-B) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 20, 2026.
En ALK-B-aktie köpt före Oct 20, 2026 motsvarar nu 0 ALK-B-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL